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ABSTRACT
Toxoplasma gondii is a ubiquitous protozoan parasite that can infect and replicate
within any nucleated mammalian or avian cell. The ability of double stranded RNA to
downregulate gene expression has been demonstrated in T. gondii. We have constructed a
tetracycline based inducible RNAi vector which can be used for regulating gene
expression in T. gondii. Upon the addition of anhydrotetracycline, the production of
double stranded RNA homologous to the target gene is induced. The inducible vector was
characterized using the marker gene, uracil phosphoribosyl transferase. The inducible
vector was stably transfected into RHtetR strain of the parasite and specifically lowered
the expression of uracil phosphoribosyl transferase detected by RT-PCR, uracil
incorporation assay and 5-fluro-2'-deoxyuridine resistance. Subsequently, the inducible
RNAi vector was used to elucidate the role of microneme protein 3 (MIC 3), which is an
invasion related gene. We generated a stable transgenic parasite line in which the
expression of MIC 3 was knocked down detected by RT-PCR. However, we did not
detect any changes in the growth of the parasite or its invasion ability, as monitored by
nucleotide uptake assay and growth assay.
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CHAPTER 1

Introduction

1.1 Toxoplasma gondii
T. gondii is a unicellular apicomplexan protozoan. The apicomplexan parasites are
characterized by the presence of a plastid acquired by secondary endosymbiosis of algae,
which is essential for parasite replication (McFadden and Roos, 1999; Coppens and
Joiner, 2001). T. gondii is globally distributed and infects a wide variety of mammals and
birds (Frenkel and Dubey, 1972). It was discovered in 1908 by Nicholle and Manceaux
from the liver of African rodent Ctenodactylus gondii (Sukthana, 2006).
In immuno-competent hosts, the parasite produces only mild clinical symptoms
and progresses to a chronic state without major complications (Krahenbuhl and
Remington, 1982). In immuno-compromised humans, recipients of organ transplants and
newborn babies, the infection can be life threatening (Kafsack et al., 2004). Primary
infection during pregnancy can cause abortion, neurological damage, pre-term birth and
visual impairment (Gilbert et al., 2001; Remington et al, 2001; Wallon et al, 2004;
Beghetto et al., 2006). T. gondii infection occurs as a result of ingestion of oocysts from
definitive hosts, cats or through tissue cysts present in undercooked meat. The transition
from acute to chronic toxoplasmosis occurs through a stage conversion of fast replicating
tachyzoite form to the cyst-forming dormant bradyzoite form. This stage conversion is
marked by a significant change in mRNA and protein expression profiles and helps the
parasite to persist in the host tissue (Dzierszinski and Knoll, 2007; Tomavo and Weiss,
2007; Friesen et al, 2008).
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1.1.1 Life cycle of T. gondii
T. gondii can infect and replicate within any nucleated mammalian or avian cell
(Wong and Remington, 1993; Dubey, 1998; Black and Boothroyd, 2000). T. gondii has a
complex life cycle. The sexual life cycle takes place only in members of the felidae (cats),
which is the parasite's primary host. The gametes are formed in the small intestinal
epithelium of the cat. Unsporulated oocysts are released into the intestinal lumen and
passed into the environment with the faeces. Sporogony occurs outside the host and leads
to the development of infectious oocysts which contains two sporocysts, each containing
four sporozoites (Dubey and Beattie., 1988; Jackson and Hutchison., 1989; Tenter et ai,
2000). The asexual life cycle takes place in warm-blooded animals and birds. Depending
on whether the infection is in the acute or chronic phase, the asexual components consist
of two distinct stages, the fast growing tachyzoite and the slow growing bradyzoite (Black
and Boothroyd, 2000).
T. gondii can enter the host either in the form of an oocyst or as a tissue cyst. The
ingested cysts multiply in the small intestine and liberate sporozoites from the oocysts or
brazyzoites from the tissue cyst. Sporozoites and bradyzyzoites infect the intestinal
epithelium and differentiate into fast growing tachyzoites which then spread throughout
the body via monocytes and macrophages (Sumyuen et al, 1995; Carruthers 2002). In
order to escape the host immune response, T. gondii differentiates from tachyzoites to
bradyzoites, which build a cyst wall to encapsulate and fortify themselves within host cell
(Bohne^o/., 1993, 1994).

Figure 1.1 Life cycle of T. gondii. The definitive hosts (feline) of T. gondii, ingests
sporulated oocysts and becomes infected (sexual cycle) and further infects other warm
blooded animals and birds (asexual cycle). Toxoplasma can also be transmitted to
intermediate hosts through oocysts, by carnivorism, or transplacentally. The most
common route of infection in sheep and humans is through trans-placental infection
(Dubey, 1986).
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1.1.2 Host cells and parasite strains
Excellent culture systems are prerequisites for T. gondii research (Grimwood et ah,
1979; Huges et ah, 1986; Roos et ah, 1994). HeLa cells (cervical epithelial cells) have
been used for the culture of tachyzoites. The two major disadvantages of using these cells
are inconsistent yield of tachyzoites and difficulty in predicting the time of lysis of these
cells (Evans et ah, 1999; Chatterton et ah, 2002). T. gondii are also cultured using Vero
cells (kidney epithelial cells obtained from African green monkey) (Cleary et al, 2002).
However, most commonly used host cells are the human foreskin fibroblasts (HFF). The
main advantages include the fact that these cells grow easily, even in the presence of
growth inhibiting drugs that are used to select stably transfected parasites. Futhermore,
the large surface area of HFFs allows the parasite to complete multiple cycles within the
cells before they are lysed (Roos et ah, 1994; Freyre, 1995).
Several strains of T. gondii are available. The virulence, replication rates and cyst
forming capabilities differ from one strain to the others (Soete et al, 1993; Fryere., 1995).
For the generation of tachyzoites, the RH strain is commonly used in laboratory. The
advantage of using the RH strain is that it replicates faster as compared to other strains
and efficiently lyses host cells releasing a large number of parasites. The main
disadvantage of the RH strain is its poor cyst-forming abilities. For generation of
bradyzoites, PLK stain is used which is known for good cyst forming capabilities
(Soete et ah, 1993; Boothroyd et al, 1997).
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1.1.3 Toxoplama as a model for apicomplexan phylum
The genera of phylum Apicomplexa include pathogens such as Cryptosporidium,
Eimeria, Neospora, Plasmodium and Theileri (Saeij et al., 2005). Cryptosporidium and
Eimeria are enteric pathogens; Neospora, and Theileri causes veterinary diseases while
Plasmodium causes malaria. T. gondii is considered to be an intracellular apicomplexan
model because it can be easily cultured, transfection can be achieved easily and genetic
studies can be done in vitro and in vivo (Kim and Weiss, 2004). Among apicomplexa, it
was T. gondii in which transfection was first reported (Kim et al., 1993; Soldati and
Boothroyd, 1993; Donald and Roos 1993). The efficiency of transient transfection is high
(above 50%) as compared to other apicomplexans. Stable transformation can also be
achieved in T. gondii. In malarial parasites the transfection efficiency is low and it can
take months to generate a stable transformant (Donald and Roos 1993). Cryptosporidium
and Eimeri cannot be maintained in tissue culture for a long time and thus it is very
difficult to perform important genetic studies. Furthermore, transient transfections can be
achieved in Eimeri but phenotypic studies cannot be done successfully since it cannot be
cultivated in vitro successfully (Kelleher and Tomly, 1998).
Large numbers of tools have been developed for genetic manipulation of T. gondii.
Gene expression has been downregulated using RNA-based techniques (Al-Anouti and
Ananvoranich, 2002; Al-Anaouti et al, 2003; Sheng et al., 2004). Since it is very difficult
to genetically manipulate most apicomplexans, T. gondii has been used as a model
expression system to study the biochemical role of certain proteins that cannot be
expressed in other organisms. The Plasmodium protein, circumsporozoite protein (CSP)
has been successfully expressed in T. gondii after codon optimization. Codon optimization
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is done to overcome the A/T codon bias of Plasmodium compared G/C preference of
T. gondii (Charest et ah, 2000). Sporozoite surface antigen gp40/15 of C. parvum, which
is also rich in A/T has also been successfully expressed in T. gondii after codon
optimization (O'Connor et ah, 2003).

1.1.4 Genetic Manipulation of T. gondii
The Toxoplasma genome has been successfully manipulated by DNA transfection
(Striepen and Soldati, 2007). DNA is introduced into tachyzoites by electroporation. The
use of cytomix, which has a composition that resembles the ionic composition of the cells,
ensures maximum survival of the cells after elctroporation (Van den Hoff et ah, 1992).
Nearly 80% tachyzoites were able to successfully invade host cells after elctroporation
with cytomix (Soldati and Boothroyd, 1993).

1.1.4.1 Transgenic expression in T. gondii
A transient gene expression occurs if the plasmids are maintained for a few days
in the parasite as episomal DNA after electroporation whereas stable gene expression
takes place if the plasmid integrates into the genome of the parasite. Stable transformation
can take place by homologous or non-homologous recombination of the plasmid into the
parasite genome (Donald and Roos, 1994).
Episomal vectors, which are able to replicate autonomously in T. gondii without
integrating into the genome have also been developed (Black and Boothroyd, 1998).
These vectors avoid the possibility to introduce mutations into the genome by nonhomologous recombination.
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1.1.4.2 Selectable markers for stable transformation
The markers used to select stable transformants in T. gondii include hypoxanthinexanthine-guanine phosphoribosyltransferase (HXGPRT) (Donald et ah, 1996), uracil
phosphoribosyltransferase

(UPRT)

(Donald

and

Roos,

1995),

chloramphenicol

acetyltransferese (Kim et ah, 1993), phleomycin resistance (Messina et ah, 1995),
dihydrofolate reductase-thymidilate synthase (Donald and Roos, 1993), and tryptophan
synthase (Sibley et ah, 1994).
T. gondii is dependent on host cells for purines as it is incapable of synthesizing
them on its own (Schwartzman and Pfefferkorn, 1982) but has the ability to interconvert
purine nucleotide that it salvages. HXGPRT can convert hypoxanthine to inosine
monophosphate (IMP), xanthine to xanthosine monophosphate (XMP) and guanine to
guanine monophosphate (GMP) (Pfefferkorn et ah, 2001). IMP can be converted to XMP
and XMP can be converted to GMP with the help of enzymes IMP-dehydrogenase and
GMP-synthase respectively. If IMP-dehydrogenase is blocked by mycophenolic acid
(MPA), then HXGPRT is required to convert xanthine to GMP. Thus MPA can be used
for positive selection for HXGPRT. HXGPRT converts 6-thioxanthine (6-TX) to 6thioxanthosine 5'-phosphate which is toxic to parasite. Therefore, 6-TX can be used for
negative selection for HXGPRT (Donald et ah, 1996).
UPRT is a parasite specific enzyme. This enzyme is used by the parasite in
pyrimidine salvage to convert uracil to UMP. In the presence of fluorouracil,
phosphoribosylation of fluoruridine leads to production of F-dUMP and results in the
inhibition of TMP synthesis. 5-fluorodeoxyuridine is metabolized to 5-fluorouracil by
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UPRT. Thus it can be used to select parasite strains that lack a functional UPRT gene
(Donald and Roos, 1995).

1.2 Genes responsible for virulence of T. gondii
The preliminary attachment of T. gondii by its apical pole involves interactions
between surface antigens of the parasite and cell surface receptors on the host cell
(Bonhomme et al., 1999). Five major surface antigens, SAG 1-5 have been identified on
the surface of T. gondii (Couvreur et al, 1998). SAG 1 and SAG 2 are tachyzoite specific
antigens that play an important role in attachment of parasite to host cell during the early
stage of invasion. Three surface antigen related sequences, SRS 1, SRS 2 and SRS 3 have
been identified but their functions are still unknown (Boothroyd et al., 1997). After the
parasite is attached to the host cell membrane, a tight junction forms between the attached
parasite and the host cell membrane, probably through surface membrane components
attached to the cytoskeletal microtubules of T. gondii. The actin-myosin motor provides
the driving force to the parasite to glide through the tight junction.
After the parasite is apically oriented, micronemal proteins (MICs) are released
(Achbarou et ah, 1991). MIC 1 and MIC 2 proteins help the parasite to intimately attach
itself to the host cell surface (Fourmaux et al, 1996). MIC 3 has an epidermal growth
factor (EGF)-like domain which suggests that micronemes contain possible ligands for
host cell receptors. After the microneme proteins are released, the rhoptries which are
club-shaped organelles excrete their contents that help to decrease the viscosity of the
host cell membrane and this helps the parasite in invagination and further enhances the
invasion process (Joiner et al., 1990).
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The rhoptry proteins also help the parasite to build the parasitophorous vacuole.
These vacuoles protect the parasites from phagocytes by preventing acidification of the
internal environment thereby avoiding the normal endocytosis process (Sibley et ah,
1993). The parasitophorous vacuoles also provide an environment for parasite growth and
development. The release of rhoptry protein is believed to be regulated by an endogenous
Ca2+-dependent phospholipase (Saffer and Schwartzman, 1991). Ten different rhoptry
proteins have been discovered so far but ROP 1 and ROP 2 are believed to play the major
role (Saffer et ah, 1992). ROP 1, also known as penetration enhancing factor, is a 61 kDa
protein. ROP 2, a 54 kDa protein is initially associated with parasitophorous vacuole but
disappears as the vacuole matures (Beckers et ah, 1994).
Dense granules are molecules that are secreted into the parasitophorous vacuole
from the time these vacuoles are formed till the parasites mature. These molecules help to
support the intravacuolar network of the membranous tubules within the lumen of the
parasitophorous vacuole. Dense granule proteins GRA 3 and GRA 5 are distributed to the
vacuolar membrane while GRA 1, GRA 2, GRA 4 and GRA 6 are distributed to the
intravacuolar network (Sibley et ah, 1995). Thus, dense granule proteins that are released
into parasitophorous vacuole may help the parasite to replicate and evade the host
immune response.

1.2.1 Microneme protein 3 (MIC 3)
T. gondii invade the host cell in a sequential manner with the aid of proteins
secreted from three secretory organelles (Carruthers and Sibley, 1997). MICs are
discharged first and they help the parasite to attach to the host cells as they can recognize
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and effectively bind to the host cell receptors (Soldati et al., 2001). After the secretion of
MICs, rhoptry proteins are released. These proteins help in the formation of
parasitophorous vacuole membrane (PVM) in the host cells in which the parasite resides
(Saffer et al., 1992). Finally, the proteins from the dense granules are released. Dense
granule proteins are released during the process of invasion as well as after the invasion
process is complete. These proteins help the parasite to survive in the intracellular
environment as well as help them during replication (Zhou et al., 2005).
Microneme protein MIC 3 is an important adhesion protein secreted by T. gondii
(Cerede et al., 2002). This protein can be observed in tachyzoite, bradyzoite and
sporozoite stage of the parasite (Ismael et al., 2003). It is synthesized as a 40 KDa
protein and then undergoes N-terminal cleavage resulting in the formation of a 38 KDa
protein, which further undergoes dimerization to form a 90 kDa active protein. MIC 3 has
five epidermal growth factor-like (EGF) domains and a lectin-like domain. EGF domain
helps in exposing the binding domain as well as binding to its escort, MIC 8
(Meissner et al., 2002). The lectin-like domain helps either in protein-protein interaction
or protein-carbohydrate interaction (Garcia-Reguet et al., 2000). The protein is
translocated to the apical region of the parasite during the process of invasion and then it
migrates to the posterior part of the parasite during invasion. The release of the protein is
regulated by the calcium ions present inside the cytoplasm of the parasite (Carruthers and
Sibley, 1999). The parasite can be stimulated to release microneme proteins even in the
absence of host cells by using thapsigargin, ammonium chloride or ethanol
(Carruthers et al., 1999). BAPTA-AM can inhibit the secretion of microneme proteins by
chelating the calcium ions. The secretion of this protein can also be inhibited by
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staurosporine, which is a protein kinase inhibitor. This implies that the secretion of
microneme is dependent on phosphorylation which is regulated by calcium ion dependent
pathway (Tomley and Soldati, 2001).

1.3 RNA interference
Fire and co-workers coined the term "RNAi" or RNA interference (Fire et al.,
1998; Zamore et al., 2000). It is a mechanism that regulates the level of transcripts by
degrading the RNA in a sequence specific manner. Three phenotypes of the mechanism
are observed and they are referred to as co-suppression or post-transcriptional gene
silencing (PTGS) in plants, quelling in fungi and RNAi in animals (Agarwal et al., 2003).
It is believed that it is a mechanism through which the cells keep a check on the
movement of transposable elements and protect themselves from viral attack. Apart from
protective functions, some of the genes involved in RNAi, such as argonaute and dicer
play a pivotal role in the development of a eukaryotic organism.

1.3.1 Discovery of RNA interference
Richard Jorgensen observed that when an exogenous transgene was employed to
deepen the purple colour in Petunia plants by over expressing the chalcone synthase
enzyme, instead of obtaining deep purple flowers, the flowers were either variegated or
colourless. Since the introduction of an exogenous transgene resulted in the suppression
of endogenous homologous gene and transgene in the colourless flower, they coined the
term "co-suppression" to explain this observation (Napoli et al., 1990).
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The mechanism of downregulation of gene by RNA interference was established
by Fire and co-workers when they discovered that introduction of double-stranded RNA
(dsRNA) could block gene expression in the nematode worm Caenorhabditis elegans
(Fire etai, 1998).

1.3.2 Mechanism of RNA interference
Recent studies have shown that the mechanism of RNA interference is a two step
process (Agarwal et al., 2003). The initiating step involves the attack on a long double
stranded RNA (dsRNA) by ribonuclease III enzymes (Zamore et al., 2000). This enzyme
cleaves the dsRNA to 21 to 25 nucleotide small dsRNA fragments called small interfering
RNA (siRNA). Long dsRNA are more effective in down-regulation compared to short
dsRNA. In order to produce the same effect as a 81-bp dsRNA, 250 times higher
concentration of 21-bp dsRNA has to be used. An effective downregulation is observed
when there is >90% homology between the dsRNA and the gene to be knocked down
(Sharp, 2001).
In the next step called the effector step (Fig. 1.2), small interfering RNA binds to a
protein complex known as RNA-induced silencing complex (RISC). RISC complex is
also known as small interfering ribonucleoprotein particles (siRNP) (Agarwal et al.,
2003). RISC is a complex of siRNA and proteins with nuclease activity that can
specifically degrade target mRNAs (Harmon, 2002). Partial purification of Drosophila
RISC complex has identified argonaute 2 as one of the components. Argonaute belongs to
the PPD family of proteins, which have characteristic PAZ and PIWI domains
(Jaronczyk et al, 2005). Dicer binds to Argonaute by interacting with the PIWI domain
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and then transfers the siRNA to the RISC complex. An ATP dependent process then
unwinds the siRNA duplex and activates the RISC complex (Nykanen et al., 2001). Once
the RISC is activated, ATP is not required to cleave the target (Hammond et al., 2000).
Argonaute then preferentially cleaves the passenger or sense strand. The RISC complex
guided by an anti-sense strand also called guide strand, then cleaves the target mRNA
between the tenth and eleventh nucleotide from the antisense (guide) strand's 5'end
(Elbashir et al., 2001; Rand et al., 2005). RNA-dependent RNA polymerase can use
double stranded siRNA as primers and can synthesize long strand of dsRNA. This step
further amplifies the effect of RNA interference, resulting in the lowering of target
mRNA and subsequently the level of target protein (Shuey et al., 2002).
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Figure 1.2 Mechanism of RNA interference. Different effector molecules can induce
RNA interference. The double stranded RNA (dsRNA) is loaded into the RISC complex.
Argonaute then cleaves the sense strand (passenger RNA), utilizing ATP in the process
and then RISC complex guided by the anti-sense (guide) strand cleaves the target mRNA.
The RISC complex, apart from degrading RNA, can inhibit translation and also take part
in chromatin remodelling (Aigner, 2007).
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1.3.3 RNA interference in T. gondii
RNA tools have been extensively used for downregulation of gene expression in
many organisms including T. gondii (Nakaar et ah, 1999, 2000; Al-Anouti and
Ananvoranich, 2002; Sheng et ah, 2004). T. gondii can be subjected to genetic
manipulation using various RNA tools including antisense RNA, ribozyme and dsRNA
(Al-Anouti and Ananvoranich, 2002; Al Riyahi et ah, 2006). These RNA tools allow for
the analysis of the function of essential genes because they do not disrupt gene expression
at the DNA level, unlike DNA transformation (Lamond and Sproat, 1993). Moreover,
these RNA tools can be used in suppressing gene expression and phenotypic studies.
Antisense RNA functions by base-pairing with mRNA to interrupt the
downstream process (translation) or the destruction of the mRNA by RNase H
(Hostomsky et al., 1994). It was employed to modify the expression of triphosphate
hydrolase (NTPase) as well as HXGPRT in T. gondii (Nakaar et ah, 1999). Ribozyme,
first discovered by Cech and Airman in 1980s, is a RNA molecule that can catalyze RNA
cleavage in site-specific fashion (Tanner, 1999). In T. gondii, engineered delta ribozyme
was successfully utilized to reduce expression of UPRT and HXGPRT (Sheng et ah,
2004). Adenosine kinase which is an important enzyme in T. gondii purine salvage
pathway has been successfully downregulated using Adenosine kinase specific siRNAs
(Yu et ah, 2009).

1

1.4 Inducible System
In order to evaluate the phenotype in a loss of function study, it is essential to
have an inducible system where one can switch 'on' and 'off the gene as required. In an
optimal inducible system, the gene regulation should be tight or the system should not be
'leaky' so that the background expression is minimal. In a good inducible system, high
level of expression of the desired gene should take place only when the inducer is present
and should be specific to the gene of interest. The inducer should not be toxic to the
organism and the most important feature of an inducible system is that the induced gene
should revert back to wild type once the inducer is removed. The inducible system should
work equally well in both in vitro and in vivo conditions (Mills, 2001).
Different eukaryotic-based inducible systems have been developed based on heat
shock, interferon y, metallothionein and hormone-dependent promoters, but the major
problems of these systems include pleiotropic effects caused by the inducer in this
systems, low level of induction and high basal transcription. Regulatable systems from
prokaryotes are being used now days to reduce the pleiotropic effect and toxicity resulting
from a eukaryotic-based inducible system. One of the widely used prokaryotic-based
inducible systems is the tetracycline (Tet) regulatable system found in Escherichia coli
(E.coli) (Yamamoto et ah, 2001).

1.4.1 Tetracycline-regulatable system
The

three

main

components

of

a

tetracycline-inducible

system

are

(1) transcriptional modulator (2) tetracycline-responsive promoter and (3) an antibiotic
that belongs to tetracycline family. In this system tetracycline repressor protein (TetR)
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from E. coii which binds to DNA in a Tet-dependent manner is used as a transcription
modulator. Tetracycline-responsive promoter is the tetR binding sequence or tetracycline
operator (TetO). Tetracycline family of drugs like doxycycline and anhydrotetracycline
(ATC) are widely used as inducers (Orth et ah, 2000). Tetracycline repressor (TetR) is
used by the gram-negative bacteria to obtain resistance from antibiotic tetracycline.
TetR regulates the transcription of TetA protein that helps to export tetracycline magnesium complex [MgTc]+ out of the cell. High expression levels of TetA lead to
nonspecific cation export from the cytoplasm leading to a change in the osmotic potential
and collapse of cells. Therefore, the expression of TetA has to be tightly regulated. As
soon as an optimal level of the level of TetA is reached, TetR binds to TetO and stops the
transcription of tetA. This strong regulatable system is modified and made use in a Tet
inducible system. TetR proteins and its mutants have been used to generate different types
if Tet-inducible systems. One of the tet-inducible systems consists of tetracyclinecontrolled trans-activator (tTA), which consists of

an activating domain of Herpes

simplex virion protein 16 (VP16) bound to TetR protein of E. coli

(Gossen and

Bujard, 1992; Meissner et ah, 2001). In the absence of tetracycline tTA binds to TetO and
in presence of tetracycline, tTA binds to tetracycline and this result in a conformational
change, because of which TetR can no longer bind to TetO. The disadvantage of this
system is that tetracycline has to be present in the cell all the time to repress tTA protein
and constitutive expression of tTA is toxic to the eukaryotic cell. To remove the toxic
effect due to constitutive expression of tTA, an auto-regulatory system was established
wherein TetO sequence was inserted within tTA promoter (Shockett et ah, 1995). A
different version of Tet-inducible system uses reverse trans-activator (rtTA) that binds to
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TetO in the presence of doxycycline and as a result the gene of interest is transcribed in
the presence of doxycycline (Mills, 2001).
The most commonly used tetracycline inducible system in protozoan parasite
takes advantage of the wild TetR protein. The TetR system has been used to control gene
expression in protozoan parasites like Trypanosoma brucei (Wirtz and Clayton, 1995),
Entamoeba histolytica (Hamann et ah, 1997), Giardia lambia (Sun and Tai, 2000) and
Toxoplasma gondii (Meissner et ah, 2001).

Objectives
The main goal of this project is to develop and characterize a tetracycline repressor based
inducible RNAi system in T. gondii. An inducible system would allow us to study the
function of various genes in T. gondii. This system can be further used to identify various
genes responsible for pathogenesis of T. gondii.

1

CHAPTER 2

Materials and Methods

2.1 Chemicals
The chemicals used in this research work are listed below.
Bio-Rad Laoratories
Bromophenol blue, Coomassie Brilliant Blue R-250, xylene cyanol
BioBasic
Ethidium bromide, tris base
BioExpress
Agarose
Fermentas
Restriction enzymes Hinf I, Not 1, Pvu II, Sac I, Xho I
GibcoBRL Invitrogen
Agar, Dulbecco's modified essential medium (DMEM), Dulbecco's phosphate buffered
saline (DPBS), minimum essential medium (MEM).
Hyclone
Cosmic calf serum
Invitrogen corporation
Antibiotic-antimycotic, proteinase K, RNase Out ribonuclease inhibitor
NewEngland Biolabs Inc.
Restriction enzymes Alu I, Bgl I, EcoR I, Kpn I, Mbo II, Xmn I.
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Promega
Molony murine leukemia virus reverse transcriptase (M-MLV), RQ1 RNase free DNase ,
lkb DNA ladder 1Kb, 100 bp DNA ladder, Restriction enzymes BamHl, Bgl II, EcoR V,
Hind 111, Not I
Qiagen
Midi prep kit for plasmid DNA isolation .
Sigma-Aldrich
Acetic acid, diethyl pyrocarbonate (DEPC), 95% and anhydrous ethanol, calcium chloride,
chloramphenicol, EGTA, formaldehyde, hydrochloric acid, lauryl sulphate, mycophenolic
acid

(MPA), sodium

citrate,

sodium

chloride,

sodium

acetate,

streptomycin,

trichloroacetic acid, xanthine.
TaKara Bio Inc.
Restriction enzymes Pvu I, Sac II.
USB
Glycerol, magnesium chloride, phenol, RNase A, sodium dodecyl sulphate (SDS)
Nucleopore
Polycarbonate filters (3 pan)
Wisent
Dialysed fetal bovine serum (DFBS)
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2.2 Generation of transgenic parasites
2.2.1 Strain of parasites
RH and RHtetR parasites were used for the present study. RH parasites were
obtained from NIH through the AIDS Research and Reagent program. The RH strain was
initially isolated from a 6 year-old boy in the year 1938 from Cincinnati, Ohio
(Sabin, 1941). The child who had the initials RH was hit with a baseball bat and died 30
days after the incident. Homogenate of his cerebral cortex when inoculated into mice
revealed the prescence of T. gondii. The isolate has since then been called the RH strain.
Since 1938, the strain has been passaged in mice in different labs and due to this
prolonged passage its pathogenicity in mice has been stabilized (Dubey, 1977) and the
strain no longer produce any oocysts in cats (Frenkel et al., 1976). The RH parasites were
cultured in confluent HFF monolayer containing EDI medium (DMEM supplemented
with L-glutamine, 10% dialyzed fetal bovine serum (DFBS) and 5 ml antibioticantimycotic (10000 unit/ml penicillin, 10000 ug/ml streptomycin, and 25 ug/ml
fungizone).
RHtetR strain was donated by Markus Meissner (Heidelberg, Germany). To
construct the RHtetR strain, a plasmid p5RT70tetR was created by cloning the TetR
sequence between EcoR land Pad sites of plasmid p5RT70/HX. Hypoxanthine-xanthineguanine phosphoribosyl transferase (HXGPRT) was used as a selection marker to express
the transgene stably in T. gondii. RHtetR strain was grown on confluent HFF monolayer
supplemented with EDI medium supplemented with 25 ug/ml mycophenolic acid and
50 ug/ml xanthine (ED1/MPA/X). RHtetR parasites that were stably transfected with
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various expression vectors were grown in ED1/MPA/X medium and selected using
20 raM Chloramphenicol.

2.2.2 Host cell
Cell culture was carried out in MSC12 class II type A/B3 biosafety cabinet
(Jouan). The parasites were grown in HFF monolayer obtained from NIH through AIDS
Research and Reagent program. The host cells were grown in D10 media (Dulbecco's
Modified Eagle's Medium (DMEM) (Gibco, Invitrogen) adjusted to pH 6.8,
supplemented with L-glutamine, 10% iron fortified Cosmic calf serum (Hyclone), 5 ml
antibiotic-antimymycotic containing 10000 unit/ml penicillin, 10000 ug/ml streptomycin,
and 25 ug/ml fungizone (Gibco, invitrogen). The cells were incubated at 37 °C in 5%
CO2 incubator (ThermoForma Model 310). The host cells were sub-cultured by adding
1 ml Trypsin-EDTA solution (0.25% trypsin, 0.35% EDTA) into a 60 mm tissue culture
plate containing confluent HFF monolayer, incubating at 37 °C for 1 minute and then
gently tapping to release the and disperse the trypsin treated cells. Fresh D10 media was
added to trypsin treated plates and the contents were split into 4 plates.

2.2.3 Transfection
Basic technique of transfection of Toxoplama gondii was used for generating
stable transfectants (Soldati and Boothroyd, 1993; Donald and Roos, 1993). Briefly,
freshly released tachyzoites from lysed host cells were pelleted down by centrifugation at
1500x g for 15 minutes. The pellet was washed with sterile Dulbecco's phosphatebuffered saline supplemented with 0.1 g/1 CaCk (DPBS) before electroporation. The

22

pellet was then re-suspended in 300 ul filter sterilized Cytomix buffer (120 rnM KCL,
0.15 mM CaCl2, 10 mM K2HP04/KH2P04, pH 7.6, 25 mM HEPES, pH 7.6, 2 mM EGTA,
pH 7.6, 5 mM MgC2) to which 2 mM ATP

and 5 mM glutathione

was added

immediately before use. 50 ug of required plasmid which was linearized with appropriate
restriction enzyme and precipitated with ethanol-sodium acetate, was re-dissolved in
100 ul cold Cytomix. The 100 ul of cold plasmid was then mixed with 300 ul Cytomix
containing parasites in a 1.5 ml centrifuge tube. The entire solution was transferred to a
2 mm BTX cuvette. The cuvette was tapped gently to release any air bubbles and then
quickly subjected to electroporation. The electroporation was done by a single 1.5 kEV
pulse at a resistance setting of 25 Q and 25 uF, using a BTX model 600 Electro Cell
manipulator.
After electroporation, the cuvette was left undisturbed for 15 minutes at room
temperature. The electroporated parasites were then inoculated into a confluent
monolayer containing the appropriate selection medium.

2.2.4 Genomic DNA isolation
Genomic DNA was isolated using DNAzol® reagent. RH or RHtetR parasites
were pelleted down by centrifugation at 5000x g for 5 minutes. The media was aspirated
out; pellets were washed with 1 ml PBS and were again pelleted down at 5000x g for
5 minutes. 1 ml DNAzol® reagent was added to the pellet and pipetted up and down
gently to lyse the cells. The sediments from the homogenate were removed by
centrifugation at 10,000x g at 4 °C for 10 minutes. This step removes the cell debris and
the RNA. The supernatant was transferred to a fresh 1.5 ul centrifuge tube and the DNA
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was precipitated with 500 ul of 100% ethanol. The sample was mixed by inversion and
stored at room temperature for 3 minutes. The precipitated DNA was collected by
centrifugation at 12000x g for 5 minutes at room temperature and washed twice with 1 ml
75% ethanol. The DNA was pelleted by centrifugation at 7500x g for 5 minutes at room
temperature. The DNA pellet was then air dried for 1 minute, re-suspended in 200 ul of 8
mM NaOH and pH was adjusted to 7 by adding 32 ul of 0.1 M HEPES. The quality of
the isolated DNA was determined by agarose gel electrophoresis and the quantity was
determined by spectrophotometeric quantification.

2.2.5 Polymerase Chain Reaction
Different PCR conditions were set up to amplify the required fragments. In
general 25 ul PCR reactions were set up containing 2.5 ul of 10X PCR buffer (100 mM
Tris-HCL, pH 8 at 25 °C, 500 mM KCL and 1% Triton® X-100), 2.5 ul of 50 mM
magnesium chloride, 0.25 ul of 2.5 mM dNTPs, 0.5 ul of each primer (10 pmol), 1 ul of
DNA and 1 unit of Taq polymerase. The PCR was set for 30 cycles (95 °C for 30 seconds,
55 °C for 30 seconds and 72 °C for 1 minute).

2.2.6 Cloning (Gateway Cloning)
Gateway cloning technique was used to generate the required clones. With the aid
of gateway technology it is possible to do parallel transfer of any number genes into or
out of multiple expression systems by simply mixing DNA, adding the required enzymes
and incubating the reaction mixture. One of the major advantages of this technique is that
DNA segments transferred using this technology maintain reading frame and orientation.
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In a LR reaction, the sequence of interest is cloned in an 'entry vector' that is
transcriptionally silent, spectinomycin resistant (spnr) and flanked by two recombination
sites (att LI and att L2). The sequence of interest is then transferred to a 'destination
vector'. The destination vector contains all of the sequence information required for
expression of the required gene of interest and is ampicillin resistant (Ampr). This
plasmid contains two recombination sites (att Rl and att R2) that flanks a gene of
negative selection, ccdB. Entry and destination vector in the presence of LR Clonase ™
reacts directionally to yield 'expression vector' and a donor vector. Selection on
ampicillin eliminates the entry vector and negative selection through the ccdB gene
eliminates the donor vector.
pCR®8/GW/TOPO®

vector

was

used

to

construct

the

entry

clones.

pCR®8/GW/TOPO® is a linear vector with single 3'-thymidine (T) overhangs so that it
can be used for TA cloning. It has topoisomerase covalently bound to it and thus it is
referred to as an activated vector. This vector is generated by treating plasmid with
Vaccinia viral topoisomerase I which binds to DNA duplex containing the sequence
CCTT and cleaves the phosphodiester backbone in one strand (Shuman, 1991). The
energy generated from the broken phosphodiester backbone is conserved in a covalent
bond between the 3'phosphate of the cleaved strand and a tyrosyl residue (Tyr-274) of
topoisomerase I. The phospho-tyrosyl bond between the DNA and the enzyme can be
subsequently attacked by the 5'hydroxyl of the original cleaved strand or by any DNA
strand with free 5'hydroxyl group, reversing the reaction and thereby releasing
topoisomerase. TOPO® Cloning takes advantage of this reaction to efficiently clone PCR
products.

2.

2.2.6.1 Generation of Entry clones
The gene of interest to be cloned into pCR®8/GW/TOPO® vector was PCR
amplified using Taq polymerase. 1 p,l salt solution (1.2 M Nacl, 0.06 M Mgcl2) was
mixed with 4 ul PCR product and then 0.5 ul TOPO® vector was added. The reaction
was mixed gently and incubated at room temperature for 5 minutes. After 5 minutes the
reaction was placed on ice until the transformation was performed using One
Shot®Machl™-TlR Chemically Competent E. coli cells.

2.2.6.2 Generation of Expression Clones
To set up the LR reaction, 0.5 ul of the required entry vector was mixed with 0.5
ul of destination vector (pT5784 atta 2.2 mCAT) and the volume was made up to 4 ul
with TE buffer. The LR Clonase™ enzyme mix was thawed on ice for 2 minutes and
vortexed twice for 2 sec to mix the contents. 1 u.1 LR Clonase™ enzyme was added to the
mixture of entry and destination vectors and the reaction was incubated at 25 °C for 1
hour. After 1 hour 1 ul of Proteinase K solution was added to the reaction and incubated
at 37 °C for 10 minutes to break down the LR Clonase™ enzyme. 1 ul of this reaction
was used for transformation in One Shot®Machl™-TlR Chemically competent E.coli
cells.

2.2.6.3 Transformation in E. coli
2.2.6.3.1 Competent cell preparation
Transformation efficient DB 3.1 cells were streaked on LB plate to obtain isolated
single colonies. One single colony was picked using a sterile toothpick, inoculated into a
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Falcon 2059 culture tube containing 5 ml LB broth and was grown for 12-16 hr in a
shaker incubator (200 rpm) at 37 °C. This 5 ml culture was then transferred into a culture
flask containing 200 ml pre-warmed LB medium and incubated at 37 °C in a shaker
incubator (200 rpm) until an O.D of 0.6 was reached. The flask was then chilled on ice for
30 minutes and then the bacterial culture was aliquoted into four, 50 ml Falcon tubes. The
tubes were centrifuged at 3000x g for 15 minutes at 4 °C in a swing bucket rotor
centrifuge. The tubes were carefully transferred to an ice bucket after discarding the
media. Nearly 5 ml media was retained in the Falcon tubes to re-suspend the pellet. 30 ml
of ice cold 100 mM calcium chloride solutions was added to the Falcon tubes, the
contents were mixed by inverting and the tubes were then centrifuged at 4 °C and 4000
rpm for 15 minutes. The pellet washed with 100 mM calcium chloride, three times the
same fashion as described above. After the last wash all of the supernatant was removed
from the Falcon tubes. The pellet in each Falcon tube was re-suspended in 1.5 ml of 200
mM calcium chloride and 30% glycerol. The competent cells were aliquoted and placed
in -80 °C immediately.

2.2.6.3.2 Transformation
A slightly modified protocol from Sambrook et al, 1989 was used for bacterial
transformation. For each transformation 20 ul of competent cells were aliquoted into a
1.5 ul microcentrifuge tube. 1 ul of the plasmid to be transformed was added to the
competent cells and mixed by gentle tapping of the microcentrifuge tube. The tube was
incubated on ice for 30 minutes and subjected to 30 sec of heat-shock at 42 °C without
shaking. 280 ul of room temperature SOC medium was added and incubated in a shaker
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incubator (200 rpm) at 37 °C for 1 hour. 50 ul of this bacterial culture was spread on LB
agar plates containing the appropriate antibiotics and incubated at 37 °C for 12-16 hr.

2.2.6.4 Identification of transformed colonies by colony PCR
Bacterial colonies were picked from agar plates using sterile 200 ul pipette tips or
toothpicks and inoculated into a 0.5 ml centrifuge tube containing 50 ul sterile water. The
tube was vortexed to evenly distribute the bacterial cells. The centrifuge tube was then
placed in boiling water or heating block that was heated to 95 °C for 5 minutes to lyse the
bacterial cells and denature DNAse. The tube was centrifuged at 12000x g for 1 minute to
remove the cell debris. 10 ul of the supernatant was transferred to a fresh 0.5 ul
centrifuge tube and left on ice until PCR reaction was set up. A 40 ul PCR reaction was
set up containing 1 ul of 2.5 raM dNTP mix, 1 ul each of upstream and downstream
primer (5 pmol/ul each), 5 ul of 10X PCR buffer (100 mM Tris-HCL, pH 8 at 25 °C,
500 mM KCL and 1% Triton® X-100), 3 ul of 25 mM MgCl2, 0.25 ul of Taq DNA
polymerase (home made) and 28.8 ul of sterile autoclaved double distilled water.

2.2.6.5 Isolation of Plasmid
Bacterial colony harbouring the right plasmids, confirmed by colony PCR were
inoculated into a Falcon 2059 culture tube containing 3 ml LB medium with appropriate
antibiotics using a sterile toothpick. The culture was incubated for 12 hr at 37 °C in a
shaker incubator at (200 rpm). 1ml bacterial culture was transferred to a micro centrifuge
tube and centrifuged at 12000x g for 10 minutes. Alkaline lysis method of plasmid
isolation was followed to further isolate plasmids. After centrifugation, the medium was
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aspirated to leave the pellet as dry as possible. The pellet was re-suspended in 100 ul of
'Re-suspension-solution 1' (50 mM Glucose, 25 mMTris-HCL pH 8, 10 mM EDTA) by
pipetting up and down until all the pellet was completely dispersed. 200 ul of 'Lysis
Buffer-solution IF (0.2 N NaOH, 1% SDS) was added to completely lyse the bacterial
cells followed by 100 ul of 'Precipitation Buffer-solution III' (3 M NaOAc, pH 5.2). The
precipitate formed was mixed by inversion and then centrifuged at 12000x g for 15
minutes at room temperature. The supernatant was carefully poured into a fresh 1.5 ul
centrifuge tube and 400 ul phenolxhloroform solution was added. The tube was vortexed
and centrifuged at 12000x g for 1 minute at room temperature for phase separation. The
aqueous phase was transferred to a fresh 1.5 ul centrifuge tube, mixed with 800 ul ice
cold 95% ethanol and centrifuged at 12000x g for 10 minutes at 4 °C. The supernatant
was decanted and the pellet was washed with 400 ul ice cold 70% ethanol. The tube was
centrifuged at 12000x g for 10 minutes and the ethanol supernatant was discarded. The
pellet was further re-suspended in 30 ul TE buffer containing 20 j^g/ml RNase A and
incubated at 37 °C for 15 minutes to degrade RNA. The quality of the DNA obtained was
analysed by gel electrophoresis and later subjected to restriction analysis or PCR.

2.2.6.6 Analysis of restriction profile to confirm the plasmid
Restriction digestions of the plasmids were performed to confirm the plasmid. The
predicted restriction profiles with respect to specific enzymes were first generated using,
Vector NTI bioinformatics tool. The restriction digestion was performed in a total volume
of 10 ul containing 2 ul plasmid DNA, 1 ul lOx buffer, 0.2 pi enzyme and 6.8 ul
autoclaved Millipore water. The reaction was mixed gently by pipetting and incubated
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overnight at 37 °C. The reaction was run on 1% agarose gel and visualized using
Alphalmager 2200 documentation and analysis system.

2.3 Gel Electrophoresis
Genomic DNA, RNA, PCR and RT-PCR products were resolved on 1% (w/v)
agarose gels.

2.3.1 Agarose gel electrophoresis
Agarose was dissolved in Tris-acetate-EDTA (TAE) buffer (40 mM Tris acetate
and 1 mM EDTA) containing lOng/ml ethidium bromide. Melted agarose was poured into
gel-casting tray with appropriate combs and allowed to cool. The combs were removed
and the gel was placed in an agarose gel electrophoresis chamber. The gel was completely
submerged with TAE buffer. 1 ul of sample to be loaded into the well was mixed 5 ul of
DNA/RNA loading dye 0.25% (w/v) Bromophenol Blue, 0.25% (w/v) xylene cyanol FF
and 30% glycerol in water. The agarose gel was run for 15-30 minutes at 120V. The gel
was then visualized using Alphalmager 2200 documentation and analysis system and the
picture was analyzed using Chemilmager V5.5.

2.4 Reverse transcription-polymerase chain reaction (RT-PCR)
2.4.1 Isolation of total RNA
Total RNA from all strains of T. gondii that was used in the study, was extracted
using TRI Reagent®. The parasites that had lysed the HFF monolayer were passed
through 26G3/8 (PrecisionGlide®) syringe needle and filtered through 3 urn filter to break
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and remove host cell debris. Centrifugation for 10 minutes at 5000x g was used to pellet
down the parasites. The pellets were further washed with 1ml phosphate buffered saline
(PBS) to wash out all the media from the parasite pellet. The pellet was lysed and
homogenized by adding 1 ml TRI Reagent® and incubating at room temperature for
5 minutes. 200 ul chloroform was added, mixed vigorously and the sample was incubated
at room temperature for 3 minutes. The sample was then centrifuged at 12000x g for 15
minutes at room temperature for phase separation. The aqueous phase was transferred to a
new microcentrifuge tube. 500 ul isopropanol was added to the aqueous phase, mixed and
stored at room temperature for 10 minutes to precipitate total RNA. Precipitated RNA
was collected by centrifugation at 12000x g for 10 minutes. The RNA pellet was further
washed with 1 ml 75% ethanol, centrifuged for 5 minutes at 7,500x g at room temperature
and air dried for 5 minutes. The RNA pellet was then dissolved in 50ul of DEPC treated
water and incubated at 55 °C for 10 minutes. 1 ul of isolated RNA was run on agarose gel
to determine the integrity of the isolated RNA and to check for DNA contamination. The
total RNA after isolation was treated with DNase to remove DNA contamination. For this
a 25 ul reaction was set up containing 16.5 ul of total RNA, 2.5 ul of 10X DNase buffer,
5 ul of 5X transcription buffer and 1 ul of DNase enzyme. The reagents were mixed
properly by pipetting and incubated at 37 °C for 15 minutes. In order to reduce loss of
RNA during phenokchloroform extraction, the volume was made up to 200 ul by adding
DEPC treated and autoclaved water. 200 ul of TE-buffered phenol:chloroform:isoamyl
alcohol (25:24:1) was added, the sample was vortexed to denature DNase

and

centrifuged at 12000x g for 5 minutes for phase separation. The aqueous phase was
transferred to a fresh 1.5 ul centrifuge tube and 0.1 volume 3 M sodium acetate and 2
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volumes of ice cold 95 % ethanol were added. The solution was mixed properly, placed at
-20 °C for 30 minutes and centrifuged at 12000x g for 5 minutes. The pellet obtained was
washed with 70% ethanol; air dried for 2 minutes and dissolved in 50 jul DEPC treated
autoclaved water.

2.4.2 Quantification of RNA
RNA has an absorbance peak at 260 nm. 2 ul total RNA was diluted into 500 ul
DEPC water placed inside the quartz cuvette. The spectrophotometer was first blanked
using DEPC water and then the absorbance of the diluted RNA was recorded. The RNA
was quantified using the using following equation:
RNA [ug/ul] = A260 X 500/2ul of RNA assayed X 40

2.4.3 RT-PCR
One microgram DNase treated total RNA from stable transformants and wild type
parasites were used as templates for the RT reaction. Briefly, 1 ug total RNA was mixed
with 0.5 ug of the required primer and the volume was made up to 15 ul. The reaction
mixture was incubated at 70 °C for 5 minutes to melt the secondary structure within the
template. The tube was immediately cooled on ice to prevent the secondary structure from
reforming. The tube was then centrifuged briefly to collect the solution at the bottom of
the tube. To this tube 50 mM Tris-HCL (pH 8.3), 75 mM KCL, 3 mM MgCl2and 10 mM
DTT were added followed by 5 ul of 10 mM dNTPs, 25 units of RNase inhibitor and 200
units of M-MLV RT enzyme. The volume was made up to 25 ul using DEPC treated
autoclaved water. The reagents were mixed by gentle flicking and incubated for 60
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minutes at 42 °C. The reverse transcriptase enzyme was inactivated by heating the
reaction mixture at 95 °C for 2 minutes.

2.5 Nucleotide incorporation assay
Freshly harvested parasites were counted using a haemocytometer and 10000
parasites were inoculated per well in a 24-well plate containing a confluent HFF
monolayer. The RH parasites were grown in EDI media, RHTetR parasites were grown
in EDI media containing mycophenolic acid and xanthine while stable transfectents in
RHTetR parasites were grown in media containing EDI with mycophenolic acid xanthine
and chloramphenicol. After 24 hr, 1 uCi [5, 6 -3H]-uracil or hypoxanthine was added per
well and incubated for 4 hr at 37 °C in 5% CO2 incubator. The 24-well plate was chilled
at 20 °C for 2 minutes and then 1 ml ice cold 0.6 N trichloroacetic acid (TCA) was added
per well into the existing medium. The plate was incubated for 1 hr to fix the HFF
monolayer. The TCA solution was pipetted out into the radioactive waste container. To
each well 500 ul Millipore water was added and the plate was put on a shaker to rinse out
the TCA solution and unincorporated radioactive material. This step was repeated at least
five times to ensure proper washing of the host cells. In order to ensure that the cells were
properly washed, 250 ul of the final wash solution was added to a scintillation tube and
mixed with 3 ml scintillation fluid and read using a scintillation counter. The washes were
done until a reading of less than 300 cpm was observed for the washes. After proper
washing of the cells the plate was dried and 500 ul of 0.1 N NaOH was added per well.
The plate was then incubated at 37 °C for 60 minutes to dissolve the TCA precipitates.
250 ul of the sample per well was mixed with 3 ml scintillation fluid and the radioactive
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count was determined using the scintillation counter. Each experiment was carried out in
triplicate.

2.6 Tolerance of transgenic UPRT knockdown parasite for 5-fluro-2'-deoxyuridine
5-fluro-2'-deoxyuridine (FDUR) is converted to 5-fluorouracil by the parasite
inhibiting the synthesis of TMP. Therefore assimilation of FDUR is toxic to the parasite.
A microtiter assay was carried out to study the ability of UPRT knockdown parasite to
grow in the presence of 5-fluro-2'-deoxyuridine. 6-thioxanthine was used as a control to
rule out drug resistance due to mutation. Briefly, FDUR and 6-thioxanthine were serially
diluted in EDI media supplemented with mycophenolic acid and xanthine using a 96-well
plate. The effect of the drug was studied under both induced and uninduced condition.
10000 parasites were added per well and the plate was incubated at 37 °C in a CO2
incubator. The HFF monolayer with parasite and devoid of drug, which acted as the
control, was observed daily for the progression of parasite growth. When the cell
monolayer was completely destroyed in control wells, the media was aspirated and the
host cells were rinsed with PBS, fixed with methanol and stained with crystal violet
(5x stock: 25 g crystal violet dissolved in 250 ml methanol was added to 1000 ml 1%
ammonium oxalate. The intensity of the stained monolayer was recorded using Alpha
Imager. Control wells containing parasite, devoid of drug were assigned an arbitrary
value of 100%. Values of other wells were calculated in comparison to control well. LD50
value was calculated from the graph that was plotted based on the obtained value.
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2.7 Analysis of the role of MIC 3 in invasion and metabolism of the parasite
RHtetR parasites that were stably transfected with MIC 3 were grown in HFF
cells containing EDI media supplemented with mycophenolic acid and xanthine, with and
without anhydrotetracycline. Freshly lysed parasites from individual plates were counted
using haemocytometer and 10000 parasites were inoculated into separate plates with and
without anhydrotetracycline. The parasites were allowed to grow for 24 hr. The infected
monolayers were fixed with 3% paraformaldehyde, and their nuclei were stained using
100 uM Hoechst stain to enable the visualization of intracellular parasites and host cells,
respectively. The number of vacuoles and number of parasites per vacuole was counted.
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CHAPTER 3

Results
The aim of this project was to develop and characterize a tetracycline repressor
based inducible RNAi system in T. gondii. RNA tools including antisense RNA,
ribozyme and dsRNA have been previously used to downregulate the expression of
T. gondii genes (Nakaar et ah, 1999, 2000; Al-Anouti and Ananvoranich, 2002; Sheng et
ah, 2004). These tools have proved to be very efficient for the study of the gene function
through loss-of function studies. An inducible system would further help us to study the
function of various genes in T. gondii. The tetracycline based inducible system will be a
valuable tool to control the expression of gene in this protozoan parasite for the study of
its pathogenesis.
The results obtained from this study are described in two sections. The first
section describes characterization of a tetracycline based inducible RNAi system that was
targeted to downregulate the marker gene uracil phosphoribosyl transferase (UPRT).
UPRT is an enzyme which is used by the parasite in the pyrimidine salvation pathway by
converting free uracil to uridine monophosphate (Schwartzman and Pfefferkorn, 1977).
The second section describes the generation of a tetracycline inducible RNAi expression
system that targets an invasion-related gene called microneme protein 3 (MIC 3). MIC 3
is required for the parasite's attachment to the host cells through recognition and effective
binding of host cell receptors (Soldati et ah, 2001).
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3.1 Inducible RNAi system against UPRT
3.1.1 Plasmid construct
To create the plasmid used for the study, a 554 bp fragment of the UPRT gene
was cloned between two head-to-head tetracycline inducible promoters. The resultant
plasmid called p5784uprtmcat was digested with restriction enzymes for confirmation.
The open reading frame (ORF) of UPRT is 735 bp long (Fig.3.1.Al). The ORF was
digested with EcoR I and the resulting fragment from 182 bp to 735 bp (554 bp) were
cloned between the head-to head promoters (Fig.3.1.A2). The plasmid was individually
digested with Sac II and Hind III to verify the construct (Fig.3.1.B). Sac II sites are
located at 624 bp, 2008 bp and 5935 bp on the plasmid. The presence of bands of 3,927
bp, 13,884 bp and 980 bp confirm the plasmid. Hind III sites are located on 423 bp, 563
bp, 641 bp, 4895 bp, and 5,784 bp. The bands of 4,254 bp, 930 bp, 889 bp, 140 bp, 78 bp
further confirmed the validity of the construct.
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Figure 3.1 Confirmation of plasmid p5784uprtmcat by restriction digestion.
(A) 1: 735 bp ORF of UPRT gene; 2: 554 bp fragment of the ORF that was cloned to
create the p5758uprt plasmid (B) Lane 1: plasmid p5784uprtmcat Sac II digest; Lane 2:
plasmid p5784uprtmcat Hind III digest (C) Vector map of plasmid p5784uprtmcat. The
region where the 554 bp UPRT gene fragment is cloned is shown by a pie section.

3.1.2 Generation and confirmation of transgenic parasites containing inducible
RNAi system against UPRT gene
To generate transgenic parasites with the inducible system, the plasmid
p5784uprtmcat was introduced into the RHtetR strain of T. gondii through electroporation.
Genomic DNA was extracted from the transgenic parasites and subjected to PCR
amplification to confirm stable integration of the plasmid. The 5784uprtmcat plasmid
contains a selectable gene that codes for chloramphenicol acetyl transferase (CAT). CAT
gene is absent in T. gondii therefore, only parasite strains stably transfected with the
plasmid will harbour this selectable gene. PCR was done using the CATEcoRImut and
SPHD'CAT primers and the presence of a 466 bp product confirmed the presence of
CAT fragment in the transgenic parasite line (Fig. 3.2). This stable line of transgenic
parasite was named RHtetRuprt.
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Figure 3.2 Confirmation of transgenic integration of plasmid p5784uprtmcat.
A 466 bp fragment was PCR amplified from the CAT coding sequence using primers
CAT_EcoRImut and SPHLVCAT. (A) Lane 1: PCR amplified product from DNA
isolated from RHtetRuprt; Lane 2: PCR amplified product from plasmid p5784uprtmcat
which was used as a positive control. (B) Vector map of plasmid p5784uprtmcat. The
CAT coding sequence that was amplified from the integrated plasmid is marked by the
pie section.

3.1.3 Confirmation of the expression of RNA homologous to UPRT in RHtetRuprt
Parasites
RT-PCR procedure was performed using primer set 1 (Fig. 3.3 A, B), to
verify if the antisense strand of UPRT is generated by the RHtetR parasite. The absence
of any product corresponding to antisense RNA against UPRT confirmed that antisense
RNA against UPRT is absent in these parasites. The transgenic RHtetRuprt strain which
harbours the dsUPRT generating plasmid should be able to generate dsUPRT and thus
antisense RNA for UPRT when the head-to-head promoters are induced. RT-PCR was
used to amplify antisense RNA from induced and uninduced RHtetRuprt parasites using
primer set 2. No product was obtained when antisense strand was amplified from
uninduced RHtetRuprt parasites. When antisense RNA was amplified from induced
RHtetRuprt parasites, the expected fragment (280 bp) was observed. These results
indicated that antisense RNA against UPRT mRNA was not expressed naturally. Further,
antisense RNA and thus dsUPRT in RHtetRuprt parasites were expressed only when they
were subjected to induction (Fig. 3.3.B).
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Figure 3.3 Confirmation of the expression of RNA homologous to the UPRT gene in
transgenic parasites. (A) Schematic representation of the UPRT ORF showing the regions
that could be amplified using specific primers (B) Amplification of antisense RNA
homologous to UPRT gene. Lane 1: 5 kb ladder; Lane 2: Amplification of ORF from
genomic DNA; Lane 3: Amplification of antisense RNA corresponding to ORF; Lane 4.
Amplification of 280 bp from 500bp UPRT fragment cloned into plasmid
p5784UPRTrncat; Lane 5: Antisense RNA corresponding to 280 bp amplified from
uninduced transgenic parasite; Lane 6: Antisense RNA corresponding to 280 bp amplified
from induced transgenic parasite; Lane 7: lOObp ladder (C) Total RNA isolated from
uninduced and induced RHtetRuprt parasites; Lane 1: Total RNA isolated from
uninduced RHtetRuprt parasites; Lane 2: Total RNA isolated from induced RHtetRuprt
parasites.

3.1.4 Confirmation that the expression of UPRT was altered in transgenic
RHtetRuprt parasites
3.1.4.1 Validation of UPRT downregulation in RH strain
To check the efficiency of the plasmid to downregulate UPRT, the plasmid was
stably transfected in the RH strain of T. gondii. The RH strain does not have the ability to
produce tetracycline repressor protein. Thus, constitutive expression of dsUPRT should
take place in the RH parasites. The UPRT dsRNA will trigger the RNAi pathway and will
result in downregulation of UPRT expression. Consequently, the parasites' ability to
salvage free uracil will be diminished.
When H uracil was introduced to the medium, it was observed that the ability of
the transgenic RH parasites to salvage uracil was considerably low (Fig. 3.4). This result
confirmed that endogenous UPRT was downregulated in the transgenic RH parasites
containing plasmid. To demonstrate the specificity of gene knockdown, the activity of the
HXGPRT gene, which is responsible for hypoxanthine uptake, was monitored by
measuring the salvage of H hypoxanthine by the parasite. The results showed that the
uptake of hypoxanthine increased with increasing number of parasites and the presence of
plasmid p5784uprtmcat did not impair HXGPRT activity. This confirmed the specificity
of the knockdown.
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Figure 3.4 Nucleotide uptake assay. The UPRT gene was downregulated in RH strain
and the ability of these parasites to assimilate 3H-uracil and 3H-hypoxanthine was
analysed.

3.1.4.2 Characterization of the inducible system in RHtetruprt strain
3.1.4.2.1 Optimization of number of transgenic RHtetR parasites
To characterize the inducible system, it was essential to work with an optimum
number of parasites. Particularly for nucleotide uptake assays, infected monolayers are
required to be intact so that the fixing and washing steps can be performed. Large number
of parasites will lyse the host cells but too few parasites results in low radioactive
emission readings that are difficult to interpret. One way to increase the radioactive
emission readings is to increase the concentration of radioactive material but this is not
advised as radioactive materials are costly.
To optimize the number of parasites to be used, different amounts of (5,000 to
30,000) parasites were inoculated into host cells. As seen in Fig. 3.5, the uptake of 3 Huracil increased with increasing number of parasites. The host cells lysed when more than
10,000 parasites were administered at 24 hr post-infection. Therefore, it was concluded
that 10,000 parasites were optimal for the nucleotide uptake assays.
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Figure 3.5 Optimization of number of the RHtetR parasites. In order to optimize the
maximum number of parasites that would grow without lysing the host cell in 24 hr, Huracil uptake assay was done with different number of RHtetR parasites.

3.1.4.2.2 Optimization of the concentration of inducer
Anhydrotetracycline (ATC) is toxic to the parasites and host monolayer at high
concentration so it was essential to optimize the amount required for the experiment.
Freshly lysed, 10,000 parasites were inoculated into each well of a 24-well plate
containing confluent HFF monolayer. Various concentrations (0 uM to 5.86 uM) of ATC
were added to the selection media, and the nucleotide uptake assay was done using the
transgenic RHtetRuprt parasites. The nucleotide uptake assay was performed with 3H
uracil and H hypoxanthine. H hypoxanthine was included in the study to measure the
toxic effect of ATC. Uptake of H hypoxanthine remained constant until 1.76 uM ATC
but it gradually decreased beyond that concentration due to the toxic effect of ATC. The
uptake of 3H uracil decreased as the concentration of ATC was increased. The decrease in
uptake of H uracil could be either due to knockdown of endogenous UPRT or due to the
toxic effect of ATC.
The result shows that 1.76 uM ATC results in a maximal induction with minimum
toxicity to the parasite (Fig. 3.6). This concentration was used for remainder of the study.
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Figure 3.6 Optimization of inducer. Different concentration of ATC was added to 10,000
parasites to check for its lethal effect on the parasite. Induction ability is depicted by the
amount of3 H-uracil uptake as UPRT is down-regulated upon induction. As a control 3Hhypoxanthine was used as parasite viability is directly proportional to 3H-hypoxanthine
uptake.

3.1.4.3 Thie UPRT expression profile of RHtetRuprt strain
The stable line of transgenic parasite RHtetRuprt was designed to express UPRT
dsRNA upon induction with ATC. After confirming the optimum concentration of ATC
that resulted in maximum induction with minimum toxicity, we verified the extent to
which the target gene was knocked down. Freshly lysed RHtetRuprt parasites were grown
in the presence or absence of 1.76 uM ATC. Induced and uninduced parasites were
collected after host cells had been completely lysed. Total RNA was extracted from these
parasites and subjected to RT-PCR using primers upstream_HincII and EcoRI_3'UPRT.
The gene expression level of UPRT and Rhoptry 1 (ROP 1) in induced and uninduced
RHtetRuprt parasites is shown in the Fig. 3.7.A. ROP 1 was used as an internal control.
The ratio of signals of UPRT/ROP 1 was calculated and the normalized UPRT expression
level in induced and uninduced parasites is shown in Fig. 3.7.B. The result shows that the
expression of endogenous UPRT mRNA level was decreased in induced RHtetRuprt
parasites as compared to uninduced parasites. Thus, these results showed that we have
been successful in generating a transgenic line of parasites called RHtetRuprt that
contains an inducible RNAi system against the UPRT gene.
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Figure 3.7 Gene expression level in transgenic RHtetRuprt parasites. These parasites
were grown without or with ATC. (A) RT-PCR of UPRT and ROP 1. Lane 1: RT-PCR of
UPRT and ROP1 gene in uninduced parasites; Lane 2: RT-PCR of UPRT and ROP1 gene
in induced parasites. (B) Expression profile of UPRT normalized against ROP 1.

3.1.5 Tolerance of RHtetR parasite for 5-fluro-2'-deoxyuridine
5-fluro-2'-deoxyuridine (FDUR) can be taken up into the parasite by the UPRT
enzyme from the media and metabolized to 5-fluorouracil, which is toxic to the parasite
(Donald and Roos, 1995). Thus, FDUR can be used to select parasite strains that lack a
functional UPRT gene. Since endogenous UPRT in RHtetRuprt parasites can be knocked
down by inducing them with ATC, their ability to tolerate FDUR was measured. Dosedependent studies were conducted to determine the concentration of FDUR that results in
50% parasite lethality (LD50). The ability of the UPRT knock down parasite to grow in
the presence of 5-fluro-2'-deoxyuridine (Fig. 3.8.A) or 6-thioxanthine (Fig. 3.8.B) under
induced and uninduced conditions was observed. 6-thioxanthine was included in the study
as a control for FDUR resistance incurred as a result of mutation due to electroporation.
The LD50 values for FDUR under uninduced and induced conditions were found to be
3±0.5 uM and 18±0.5 uM respectively. The LD50 values for 6-thioxanthine was 110±0.5
uM and 115±0.5 uM in the uninduced condition and induced condition respectively.
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Figure 3.8 Tolerance of RHtetRuprt for FDUR. RHtetRuprt parasites were grown in the
presence of FDUR (Figure A) or 6-thioxanthine (Figure B) under induced and uninduced
conditions. The LD50 values for FDUR under uninduced and induced condition were
found to be 3±0.5 uM and 18±0.5 uM. The LD50 values for 6-thioxanthine under
uninduced and induced conditions were found to be 110±0.5 uM and 115±0.5 uM
respectively.

Section 1 Summary
Thus, from the above experiments it can be concluded that we have been
successful in generating a transgenic parasite line, RHtetRuprt that contains a tetracycline
inducible RNAi system against the UPRT gene. The head-to-head promoters are efficient
in producing dsRNA which can downregulate UPRT gene expressioa The tetracycline
inducible system can effectively modulate the level of gene expression depending on the
amount of inducer added. An optimal level of induction was achieved at a concentration
of 1.76 uM anhydrotetracycline. Furthermore, an LD50 assay has shown that when
RHtetRuprt parasites are induced they become more tolerant to FDUR. This finding has
confirmed that the UPRT gene is downregulated in these induced parasites and thus the
inducible RNAi system is functional. Therefore it can be concluded that this tetracycline
inducible system can be used to downregulate genes in T. gondii and can prove to be a
valuable tool to study gene function through loss-of-function studies and phenotype
analysis.
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3.2 Inducible RNAi system directed against an invasion related gene: MIC3
When the parasite comes in contact with any nucleated cell, microneme proteins
(MICs) are the first proteins to be released (Soldati et ah, 2001). Microneme proteins
possess domains that recognize the host cell receptors and help the parasite to effectively
bind to them thus contributing to the virulence of the protein. MIC 3 is an adhesion
protein in the microneme family of protein that is secreted by T. gondii (Cerede et ah,
2002). MIC 3 was downregulated to study the resulting phenotype.

3.2.1 Generation of MIC 3 expression vector
We generated a tetracycline inducible RNAi vector called pCR8GWMIC3, that
can produce dsRNA homologous to the MIC 3 gene and could be used to downregulate
endogenous MIC 3 mRNA. To create this vector a 404 bp MIC 3 fragment was PCR
amplified from genomic DNA (Fig. 3.9.A, B) and cloned to pCR8GWTOPO to generate
an entry vector. The entry vector was digested with Pvu II to confirm the validity of the
plasmid (Fig. 3.9.C). Pvu II sites are located on 122 bp, 2,310 bp and 3,018 bp on the
entry vector. The presence of bands of 2,188 bp, 708 bp and 325 bp confirmed the correct
plasmid. The Gateway cloning strategy was used to create the expression vector and is
described in detail in "Material and Methods" section 2.2.6. The destination vector used
generate the expression clone was also digested for its confirmation (Fig. 3.9.D). The
destination vector was digested individually with Hind HI, Pvu II and Bgl I. Hind III sites
are located on 423 bp, 563 bp, 641 bp and 4,895 bp on the destination vector. The
digestion resulted in four bands of 4,254 bp, 3,346 bp, 140 bp and 78 bp. Bands of 4,254
bp and 3,356 bp can be clearly seen on the gel. Bands of 140 bp and 78 bp were too small
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to be observed clearly. Pvu II sites are located on 1,114 bp, 2,235 bp, 4,748 bp and 7,306
bp. Pvu II digest yielded four bands of 2,558 bp, 2,513 bp, 1636 bp and 1,121 bp. Bgl I
sites are located on 3,424 bp, and 4,691 bp. This digestion resulted in two bands of 6,561
bp and 1,267 bp. In order to obtain the expression vector an LR recombination reaction of
destination vector and entry vector was done using LR Clonase™. The expression vector
pCR8GWMIC3 obtained was analysed by restriction digestion (Fig. 3.9.G). Plasmid
pCR8GWMIC3 was individually digested viithAge I and Pvu I. Age I sites are located on
401 bp, 1,963 bp, 4,890 bp and 5,120 bp. Bands of 2,930 bp, 1,562 bp, 1,325 bp and 227
bp confirmed the validity of the expression vector. Pvu I sites are located on 4,737 bp,
and 3,692 bp and the bands of 4,999 bp and 1,045 bp further confirmed the validity of the
pCR8GWMIC3 plasmid.

5

Figure 3.9 Construction and validation of MIC 3 entry vector (A) Genomic DNA was
isolated from the RH strain. Lane M: 1.5 Kb ladder; Lane 1: Genomic DNA. (B) MIC 3
was amplified from genomic DNA isolated from the RH strain. Lane M: 100 bp ladder;
Lane 1: PCR amplified 404 bp fragment of MIC 3. (C) To validate the entry vector, it was
digested with restriction enzyme Pvu II. Lane 1-4: MIC 3 entry vector digested with Pvu
I; Lane 5: undigested vector. (D) The Destination vector was digested with restriction
enzymes, individually with Hind III, Pvu II and Bgl I. Lane 1: undigested destination
vector; Lane 2: destination vector Hind III digest; Lane 3: destination vector Pvu II
digest; Lane 4: destination vector Bgl I digests. (E) Vector map of destination vector. (F)
The vector was digested with restriction enzymes Age I and Pvu I. Lane 1: undigested
plasmid pCR8GWMIC3; Lane 2: plasmid pCR8GWMIC3 Age I digest; Lane 3: plasmid
pCR8GWMIC3 digested with Pvu I. (G) Vector Map of expression vector
pCR8GWMIC3.
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3.2.2 Generation and confirmation of transgenic parasites containing inducible
RNAi system against MIC 3 gene
The pCR8GWMIC3 plasmid was electroporated into the RHtetR parasite to obtain
a stable line of transgenic parasites called RHtetRmic3. To confirm the stable integration
of plasmid pCR8GWMIC3, genomic DNA was extracted from the transgenic
RHterRmic3 and RHtetR parasites and subjected to PCR amplification of the CAT
fragment. PCR was done using primers CATEcoRImut and SPHB'CAT. No PCR
product was observed in the lane corresponding to RHtetR while the presence of a 466 bp
amplified product confirmed the presence of CAT in the transgenic parasite RHterRmic3
(Fig. 3.10.A). To further validate the stable transformation, DNA was extracted from the
transgenic RHterRmic3 and RHtetR parasites and subjected to PCR amplification of the
fragment located between the tub 5 promoter and MIC 3 fragment. PCR was done using
primers BamHl 5'pTUB5 and MIC3_sense. No PCR product was observed in the lane
corresponding to RHtetR while the presence of 1126 bp amplified product confirmed the
presence of the plasmid in transgenic RHterRmic3.
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Figure 3.10 Confirmation of transgenic integration of plasmid pCR8GWMIC3.
A 466 bp fragment was PCR amplified from the CAT coding sequence using primers
CAT_EcoRImut and SPHD'CAT (A) Lane 1: PCR amplified product from plasmid
pCR8GWMIC3, used as a positive control; Lane 2: PCR amplified product from DNA
isolated from RHtetRmic3; Lane 3: PCR amplified product from DNA isolated from
RHtetR parasites, used as negative control. (B) Vector map of plasmid pCR8GWMIC3.
The part of the CAT coding sequence that was amplified from the integrated plasmid is
marked by the pie section (C) A 1126 bp fragment was amplified spanning tubulin 5
promoter regions and MIC 3 fragment cloned into pCR8GWMIC3 plasmid using primers
BamHl 5'pTUB5 and MIC3_sense, Lane 1: PCR amplified product from plasmid
pCR8GWMIC3; Lane 2: PCR amplified product from DNA isolated from RHtetRmic3
parasites; Lane 3: PCR amplified product from DNA isolated from RHtetR parasites,
used as negative control (D) Vector map of plasmid pCR8GWMIC3. The 1126 bp
fragment that was amplified from the integrated plasmid is marked by the pie section.
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3.2.3 Modulation of MIC 3 expression level in transgenic RHtetRmic3 parasites
After confirming the stable integration of the plasmid, experiments were
conducted to check if these transgenic parasites are capable of downregulating
endogenous MIC 3 mRNA levels upon ATC induction. Freshly lysed RHtetRmic3
parasites were grown in the presence or absence of 1.76 uM ATC. Induced and
uninduced parasites were collected after the host cells had been completely lysed. Total
RNA was extracted from these parasites and subjected to RT-PCR to check the
expression of endogenous MIC 3 mRNA transcripts. The gene expression levels of MIC 3
and ROP 1 in induced and uninduced RHtetRmic3 parasites is shown in the Fig. 3.11.A.
ROP 1 was used as an internal control. The ratio of signals of UPRT/ROP 1 was
calculated and the normalized MIC 3 expression levels in induced and uninduced
parasites are shown in Fig. 3.1 l.B.
The normalized expression level for MIC 3 in uninduced RHtetRmic3 parasites
was given an arbitrary value of 1. Compared to uninduced parasites, the induced parasite
had a value of 0.26. These results confirmed successful generation of a transgenic line of
parasites called RHtetRmic3 that contains an inducible RNAi system against the MIC 3
gene.
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Figure 3.11 Gene expression level in transgenic RHtetRmic3. The parasites were grown
without or with ATC (A) RT-PCR of MIC 3 and ROP 1. Lane 1: RT-PCR of MIC 3 and
ROP 1 gene in uninduced parasites; Lane 2: RT-PCR of UPRT and ROP1 gene in
induced parasites. (B) Expression profile of UPRT normalized against ROP 1.

3.2.4 The effect of MIC 3 downregulation on invasion ability of the parasite
The MIC 3 gene was downregulated to study its possible role in parasite invasion.
RHtetRmic3 parasites were grown in presence and absence of ATC. Freshly lysed
parasites were counted using a haemocytometer and 10,000 induced and uninduced
parasites were inoculated into each well of a 24-well plate containing confluent HFF
monolayer. The parasites that were initially induced were further allowed to grow in
media containing 1.76 uM ATC while the uninduced were grown without ATC. A
nucleotide uptake assay was done using 3H uracil and 3H hypoxanthine. These radioactive
nucleotides served as metabolic labels to measure the viability of the parasites. If MIC 3
plays a role in invasion, down regulation of the gene would have resulted in decreased
invasion ability compared to uninduced parasites thus the uptake of the nucleotide should
have decreased accordingly. The results show that both the induced and uninduced
parasites were able to salvage almost equal amounts of nucleotides from the media; this is
indirect evidence that almost equal number of induced and uninduced parasites invaded
the host cell (Fig. 3.12.A). This shows that MIC 3 does not play a role in invasion of the
parasite and thus does not contribute to the virulence of the parasite. Since the nucleotide
uptake assay is an indirect method to check the invasion ability of the parasite, a more
direct method we employed to analyse the invasion ability of the parasite was to count the
number of vacuoles formed by the parasites over a given period of time.
In order to analyze the number of vacuoles formed by the parasites, they were
grown in 60mm plates in the presence and absence of ATC. After they lysed the host cells,
10000 parasites were introduced into fresh host cells, allowed to grow with or without the
inducer and the number of vacuoles formed in 24 hr were counted (Fig. 3.12.B). Ideally,
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if MIC 3 plays a role in parasite invasion, the number of vacuoles produced by induced
parasites should have been less than the number of vacuoles produced by uninduced
parasites. The results showed that there is a negligible difference in the number of
vacuoles formed by the induced and the uninduced parasites. The P value of 0.478
obtained from the graph suggests that there is no statistical significance in the difference
between the number of vacuoles obtained from the induced and uninduced parasites
(Fig.3.12.C).
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Figure 3.12 Effect of MIC 3 downregulation on parasite's invasion ability.
(A) RHtetRmic3 were grown in the presence and absence of ATC and allowed to invade
host cells. The amount of 3H-uracil (•) and 3H-hypoxanthine (•) assimilated is directly
proportional to the number of parasites and indirectly indicates the number of parasites
that could invade the host cells. (B) Schematic representation of invasion assay. (C)
RHtetRmic3 parasites were grown in the presence (•) or absence (•) of ATC and
allowed to invade host cells and then total numbers of vacuoles were counted
(P value =0.478).

3.2.5 The effect of MIC 3 downregulation on parasite metabolism
To check if MIC 3 has a possible role in the metabolism of the parasite, it was
downregulated

by

induction.

Freshly

lysed

parasites

were

counted

using a

haemocytometer and 10,000 parasites were inoculated per well of a 24-well plate
containing confluent HFF monolayer. The parasites were allowed to successfully invade
the host cells for 45 minutes. Induction was initiated by adding 1.76 uM ATC to the
media containing the parasites. A nucleotide uptake assay was done using 3H uracil and
H hypoxanthine as a measure of metabolic activity: if MIC 3 played a role in metabolism
of the parasite, induced parasites would be less metabolically active compared to the
uninduced and would assimilate less nucleotide. The results showed that both induced
and uninduced parasites have the same metabolic rate as they assimilated almost equal
amount of nucleotide (Fig. 3.13. A).
Freshly lysed parasites were counted using a haemocytometer and 10,000
parasites were grown in 60 mm plates in the presence and absence of ATC. Upon lysis,
the parasites were re-introduced into fresh host cells, allowed to grow with or without the
inducer and the number of parasites per vacuole was counted after 24 hrs (Fig. 3.13.B). If
MIC 3 had a role in metabolism, downregulation of the gene would have affected the
growth and division of the parasites, and thus the number of parasites per vacuoles would
have been less when compared to uninduced parasites. The results show that there is a
negligible difference in number of parasites per vacuole in induced and uninduced
parasites, displaying that the knockdown of MIC 3 does not affect metabolism of the
parasite (Fig. 3.13.C).
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Figure 3.13 Effect of MIC3 d o w n r e g u l a t i o n on p a r a s i t e m e t a b o l i s m .
(A) RHtetRmic3 parasites were grown in the presence and absence of ATC and allowed
to invade host cells. The amount of H-uracil (•) and H-hypoxanthine (•) assimilated is
directly proportional to the number of parasite and indirectly indicates the metabolic rate
of the parasite. (B) Schematic representation of the assay. (C) RHtetRmic3 parasites were
grown in the presence (•) or absence (•) of ATC and allowed to invade host cells and
then total numbers parasites per vacuole was counted.

Section 2 Summary
Microneme protein MIC 3 is an important adhesion protein secreted by T. gondii. A
tetracycline based inducible system was used to downregulate this gene in RHtetR strain
of T. gondii. A stable line of the transgenic parasite, RHtetRmic3 was successfully
created that produces dsRNA homologous to MIC 3 upon induction with ATC. The MIC
3 gene was downregulated to study its affect in transgenic RHtetRmic3 parasites. The
results suggest that though MIC 3 protein has an adhesive domain, it does not directly
play a role in invasion. A possible role of this protein in metabolism was also analyzed.
The results suggest that MIC 3 does not directly play a role in parasite metabolism.
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CHAPTER 4

Discussion

T. gondii is a protozoan parasite which has a worldwide distribution (Luft and
Remington, 1992). Toxoplasmosis, the disease caused by T. gondii, leads to congenital
diseases as well as results in abortion in humans and animals. In immuno-compromised
people such as AIDS patients, T. gondii causes encephalitis. The treatment of the disease
is very difficult as the drugs that are currently available are very toxic.
A considerable amount of research has been done in recent years to develop a
vaccine against Toxoplasma for both human and animals (Buxton and Innes, 1995).
Currently, there is no vaccine available that could be used by humans against this
protozoan parasite. A commercial vaccine has been developed against ovine
toxoplasmosis using a live attenuated S48 strain of T. gondii (Araujo, 1994). This type of
vaccine is not suitable for human use as these attenuated parasites may revert back to wild
type and can lead to infection. Various surface antigens present during the tachyzoite
stage of the parasite life cycle such as SAG 1, SAG 2 and SAG 3 have been identified as
potential candidates for vaccines and research is going on to develop a human vaccine
(Couvreur et ah, 1988).
In order to develop vaccines that can be used by humans or drugs that could treat
toxoplasmosis, it is essential to have a thorough knowledge about the parasite itself.
Determination of genes responsible for the pathogenesis associated with toxoplasmosis
and further elucidation of roles of these genes, would allow production of drugs and
vaccines against this protozoan parasite. Genes can be downregulated to decipher their
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potential role and RNA tools have been extensively used for this purpose in many
organisms including T. gondii (Nakaar et ah, 1999, 2000; Al-Anouti and Ananvoranich,
2002; Sheng et ah, 2004). In T. gondii, genetic manipulation can be done using various
RNA tools including antisense RNA, ribozymes and dsRNA (Al-Anouti and
Ananvoranich, 2002). To study the role of a gene or the phenotype as a result of loss-offunction, it is desirable to have an inducible system where one can switch the gene 'on'
and 'off as required (Mills, 2001). The tetracycline inducible system has been
successfully used to control expression of genes in various protozoan parasites, including
T. gondii (Meissner et ah, 2001).

4.1 Characterization of inducible promoter using marker gene, UPRT
The inducible RNAi vector has two main components as follows: 1. Head-to-head
promoters that would generate the double stranded RNA which would take part in the
presumed RNAi pathway to knock down the gene of interest that is cloned between them
and 2. The transcription of the desired genes could be induced. The head-to-head
promoter system consists of two promoters that are arranged in inverted repeats with the
gene of interest to be downregulated cloned between them. The inverted promoter would
allow the transcription of both strands of DNA sequence placed between them. The
head-to-head promoter system has been previously used in Trypanosoma brucei to
downregulate genes like TUB, FLA1 and GFP (LaCount et ah, 2000). The head-to-head
promoter system was also previously used in our laboratory to knock down UPRT gene
using SAG 1 promoters (Al-Anouti et ah, 2003). Tetracycline based inducible system has
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been previously used in T. gondii to downregulate myosin A protein (Meisner et ah,
2001).
The tetracycline repressor protein (TetR) from E. coli was cloned into T. gondii,
which binds to tetracycline operator elements (tetO) placed between the tub promoters,
preventing the transcription. This system is a modified form of the tightly regulated,
tetracycline-controlled gene expression system described by Gossen and Bujard (1992).
When the system is induced with ATC, dsRNA is expressed, which results in suppression
of the gene targeted by the dsRNA through RNAi. Thus, the system tightly regulates the
expression of dsRNA and the gene that the dsRNA targets-in response to the
concentration of ATC.
We have constructed a tetracycline inducible RNAi vector with head-to-head tub
promoters with TetO placed between them. A stable line of RHtetRuprt parasites was
generated containing the inducible RNAi vector. PCR using DNA extracted from
transgenic RHtetRuprt parasites showed stable integration of the inducible vector. Uracil
incorporation data indicated that uracil incorporation was lowered when RHtetRuprt
parasites were induced with ATC to produce dsRNA against UPRT.
A major disadvantage of TetR dependent inducible system is the leakiness, which
is determined by the affinity strength of TetR/TetO, within the inducible promoter (Zhang
et al., 2007). Interestingly, in our study it was observed that the background or leaky
expression of dsRNA was extremely low in the absence of the inducer (Fig. 3.6).
To further characterize the phenotype of RHtetRuprt parasites, a drug tolerance
assay was conducted for 5-fluoro-2'-deoxyuridine (FDUR). The UPRT knockdown
parasites were six times more resistant to the drug compared to the uninduced parasites.
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6-thoxanthine was included in the study as a control to confirm that the resistance to
FDUR was not a result of mutation due to electroporation. Both induced and uninduced
parasites were less sensitive to 6-thoxanthine compared to FDUR. Detection of antisense
RNA and downregulation of mRNA in these parasites show that double stranded RNA is
produced and at the same time hints to the presence of an RNAi like mechanism of
downregulation in T. gondii.
Taken together, our results indicate that the prokaryotic tetracycline-inducible
expression system is highly suitable for controlled gene expression in T. gondii. The
inducible RNAi system was able to effectively downregulate the UPRT gene upon
induction and tight regulation of the tetracycline repressor promoters showed that this
system could be used to study the function of any gene that is cloned between them
through loss-of-function studies.

4.2 Phenotype analysis of MIC 3 using an inducible RNAi vector
Microneme proteins are secreted by T. gondii in the early stage of invasion
(Soldati et al., 2001). These proteins contain adhesive domains that help them to bind
host cell surface receptors and thus help in invasion. MIC 3 has a lectin-like domain as
well as several epidermal growth factor-like domains that can help the parasite to bind to
the host cell surface receptor.
The nucleotide uptake assay is done to determine the ability of the parasite to
salvage nucleotides from the surrounding medium. The results obtained can be interpreted
to find out the relative number of parasites that have successfully invaded the host cells as
well as the metabolic rate of the parasites. The nucleotide uptake assay shows that upon
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downregulation of MIC 3, there was no significant difference in the uptake of nucleotides
in downregulated RHtetRMIC3 parasites as compared to wild type RHtetR parasites. The
result obtained here agrees with the results obtained from complete knockout of the MIC
3 gene (Ismael et al., 2006). There was about same number vacuoles as well as parasites
per vacuole in induced and uninduced parasite.
The endogenous MIC 3 mRNA level was effectively knocked down using the
tetracycline inducible RNAi vector but there was no change in either invasion or
metabolism of MIC 3 knocked down parasites compared to the wild type RHtetR parasite.
Due to the presence of lectin-like domain, MIC 3 has strong affinity towards the host cell
surface (Cerede et al, 2002). Apart from MIC 3, other MICs like MIC 1 and MIC 8 also
have lectin-like domain. Therefore, when we observed that MIC 3 downregulation did not
alter the invasion ability of the parasites, we hypothesized that other MICs may have
compensated for the loss of MIC 3. Previous studies have shown that single deletion of
either MIC 1 or MIC 3 slightly reduced virulence in vivo but when both MIC 3 and
MIC 1 were knocked out, the parasites were severely impaired in virulence (Cerede et al.,
2005).

4.3 Generation of mini inducible RNAi library
In order to study the possible genes that might be responsible for pathogenesis in
T. gondii using the inducible RNAi vector a mini RNAi library was generated. The mini
library consisted of various surface antigens, microneme proteins and lactate hydrogenase
gene 1 (LDH 1). Various genes used to construct the mini library and verification of these
constructs has been explained in detail in Appendix II and Appendix III.
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Future work
In this study we have shown that the tetracycline inducible system is able to
effectively knockdown the gene of interest upon induction. Thus, the inducible vector can
be further used to screen genes responsible for virulence of T. gondii. We have not been
able to show here that the induction is reversible. The main aim of creating an inducible
system is to study reversible regulation of gene expression. Thus future work should be
aimed to study the reversibility of induction.
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Appendix I
List of oligonucleotide primers used in the study

CAT EcoRImut 5'
SPHD'CAT
ROP1-forward
ROP1-reverse
Nsi I-UPRT
upstream Hindi
EcoRI on3'UPRT
MIC3 antisense
MIC3 sense
LDHORF (sense)
LDHORF (antisense)
BaraHI 5' Ptub5

GATGAATGCTCATCCGGAGTTCCGTATGGCAATGAAAGACG
AAAGCATGCCCCGCCCTGCCACTC
GGAACATGGGCCACAG
CGCCGAAAGCGTCTCTG
TGCATGCATATAGGCGCAGGTCCCAGCGAGC
CGACATTAGAGATCGCTGGGT
AAAGAATTCCAAAGTACCGGTCACCG
AGTGAAGGCAAGCCATGTCGAAAC
CATGTGTAGCTGACTGAATCGACG
ATGGCACCCGCACTGGT
CGTTTCGGCTCCACTCG
AATTGGGATCCGGTCGACGG
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Appendix II
Restriction profile of entry vectors

M

SAG1

SAG2A

SAG3

SAG4A

SAG4B

2779 bp

M

SAG5C

SRS1

SRS2

SRS3

SRS4

ECOR1

Fig A.1 Restriction profile of entry vectors of various surface antigens (SAG). Genes
coding for various surface antigens were cloned into plasmid pCR8GWTOPO to create
their respective entry vectors. Restriction digestion with EcoRl was done to confirm these
clones. 2779 bp product represent the pCR8GWTOPO vector backbone

M2AP
EcoR1

-

M
+

TOPO CJorting site
ecoRI(3366!

2799 bp

attL1
GW1 primer\
M13 (-20) forward primer
rrnB T1 transcription terminator
rrnB T2 transcription terminator

TOPO Cloning site
a»ra (567)
GW2 primer
attL2
M13 reverse primer
Spn promoter

577 bp

pUC origin

SpnR

B

Fig A.2 Restriction profile of M2AP entry vector. (A) Genes coding for M2AP was
cloned into plasmid pCR8GWTOPO to create the M2AP entry vector. Restriction
digestion with EcoRl was done to confirm the clones. 2779 bp product represent the
pCR8GWTOPO vector backbone (B) Vector map of M2AP entry vector

^
LDH1
PVUII

+

M
-

-307 bp

B

Fig A.3 Restriction profile of LDH 1 entry vector. (A) Genomic DNA was isolated
from RH strain of T. gondii and resolved onl% agarose gel. (B) 317 bp fragment of LDH
1 gene was PCR amplified from genomic DNA using the primer pair LDHORF (sense)
and LDHORF (antisense) (C) 317 bp fragment of LDH 1 gene was cloned into plasmid
pCR8GWTOPO to create LDH 1 entry vector. Restriction digestion with PVU II was
done to confirm this clone.

Appendix III
Restriction profile of expression vectors

attB2
a»RI(59313\

TOPO Cloning sitef
TOPO Cloning site
\l
feoRi{560«)

5622 bp

attB1
T57
lacZ fragment
mCAT-CDS
F10RI

325 bp

ColE1 ORI

B

Fig A.4 Restriction profile of LDH 1 expression vector. (A) LDH 1 expression vector
was digested with EcoR 1 to confirm the validity of the vector. The digested product was
resolved on 1 % agarose gel (B) Vector map of LDH 1 expression vector

5622 bp

a«B2
EcoRt
TOPO Cloning site\J
TOPO Cloning site
£coRf
attB1
T57

mCAT-CDS

lacZ fragment
F1 ORI
577 bp

B

Fig A.5 Restriction profile of M2AP expression vector. (A) M2AP expression vector
was digested with EcoR 1 to confirm the validity of the vector. The digested product was
resolved on 1 % agarose gel (B) Vector map of M2AP expression vector

#*

.&
cST
attB2

SKam

-5622 bp

TOPO Cloning site

•HPsT
(Seated *j3

^B»«-»V

TOPO Cloning site

£coRI(5606)

-1218 bp

mCAT-CDS

attB1
T57

lacZ fragment
Plac
F1 ORJ
CoEIORI
AP'

B

Fig A.6 Restriction profile of SAG 2A expression vector. (A) SAG 2A expression
vector was digested with EcoR 1 to confirm the validity of the vector. (B) Vector map of
SAG 2A expression vector

j r
JP

,%
attB2
B»ra{6743)\

T84

TOPO Cloning site
EcoRI (6435)
EcoRI (6220)
5622 bp

TOPO Cloning site
ECORI (5606)

attBl"
T57

^ mCAT-CDS

lacZ fragment
614 bp

Plac
F1 ORI

308 bp
215 bp

CofEl ORI
APr

B
Fig A.7 Restriction profile of SRS 2 expression vector. (A) SRS 2 expression vector
was digested with EcoR 1 to confirm the validity of the vector. The digested product was
resolved on 1 % agarose gel (B) Vector map of SRS 2 expression vector.
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